Exercise Effects on Adipose Tissue Structure and Function

Not Applicable

Recruiting

• Conditions: Obesity; Metabolic Disease; Weight Gain; Metabolic Syndrome; Insulin Resistance; Weight Loss
• Interventions: Behavioral: No exercise; Behavioral: Exercise

• Registration Number: NCT04812314
• Lead Sponsor: University of Michigan

Brief Summary

Participants will be randomized into one of two different experimental groups: 1) Exercise group and 2) No exercise (control group). Subject participation in the study will involve a series of metabolic tests before and after participants undergo a 10% weight loss program (with or without exercise training depending on group randomization). After completing this weight loss portion of the study, participants will then be required to adhere to a high calorie diet program to regain half of the weight the participant lost - followed by the same series of metabolic tests.

Detailed Description

Exercise is among the first line treatments for obesity and obesity-related diseases, yet it is shocking how little is known about how exercise works to improve health. Expanding the knowledge about novel exercise-induced adaptations in fat tissue of obese individuals and furthering the understanding about mechanisms underlying these adaptations could lead to innovative approaches for preventing and treating insulin resistance and obesity-related diseases.

Overall, the researchers believe that exercise training modifies key processes in subcutaneous fat tissue that may contribute to an increase body fat storage capacity (without increasing fat mass). The research team anticipates that exercise will evoke an even more potent adaptive response when fat tissue is dynamically changing in response to alterations in nutritional status (i.e., weight loss and weight regain).

Participants will be randomized into one of two different experimental groups: 1) Exercise group and 2) No exercise (control group). Subject participation in the study will involve a series of metabolic tests before and after participants undergo a 10% weight loss program (with or without exercise training depending on group randomization). After completing this weight loss portion of the study, participants will then be required to adhere to a high calorie diet program to regain half of the weight the participant lost - followed by the same series of metabolic tests. After the participant completes the study, the study team will help the participant to lose more weight. Total involvement in the study for each participant will likely be about 8-10 months.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2021-03-01
• Study First Submitted: 2021-03-19
• Study First Submitted QC: 2021-03-19
• Study First Posted: 2021-03-23
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-19
• Last Update Posted: 2024-06-21
• Primary Completion: 2026-03-01
• Study Completion: 2030-03-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

• Age: 18-40
• Body Mass Index: 27-45 kg/m2
• No regularly planned exercise/physical activity for at least 6 months
• Women must have regularly occurring menses and must be premenopausal

Read More

Exclusion Criteria

• Evidence/history of cardiovascular or metabolic disease
• Medications known to affect lipid or glucose metabolism, or inflammation
• Weight instability ≥ ± 6 pounds in the last 3 months
• Tobacco or e-cigarette users
• Women must not be pregnant or actively lactating

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
No exercise	No exercise	Subjects assigned to this group are to remain sedentary (no planned physical exercise) throughout the duration of the study.
Exercise	Exercise	This exercise prescription represents a common or "conventional" form of physical activity (e.g., moderate/brisk walking). If assigned to this group, participants will perform 45 minutes of moderate intensity continuous steady-state exercise at 70% maximal heart rate (HRmax) to expend 250 calories 4 days per week.

Primary Outcome Measures

Name	Time	Method
Adipose Tissue Fibrosis	30 minutes	measured histologically using Sirus Red Staining, quantified using ImageJ software at each clinical visit appointment.
Muscle Capillarization	30 minutes	measured immunohistochemically using an antibody for CD31, quantified using ImageJ software at each clinical visit appointment.
Adipose Capillarization	30 minutes	measured immunohistochemically using an antibody for CD31, quantified using ImageJ software at each clinical visit appointment.
Fat Cell Size	3 minutes	measured histologically using Hematoxylin and eosin (H \& E) staining, quantified using ImageJ software at each clinical visit appointment.
Oral Glucose Tolerance Test (OGTT)	2 hours	A test in which glucose is given and blood samples taken afterward to determine how quickly it is cleared from the blood will be completed at each clinical visit appointment..

Secondary Outcome Measures

Name	Time	Method
Blood Lipid Profile	15 minutes	A panel of blood tests that screens for abnormalities in blood lipids will be measured at each clinical visit appointment.
Blood Pressure	10 minutes	The pressure of circulating blood against the walls of blood vessels will be measured at screening and each clinical visit appointment.

Trial Locations

Locations (1)

University of Michigan; 🇺🇸 Ann Arbor, Michigan, United States